Table 3.
Variable | Healthy controls <50 years (N=48) | Healthy controls ≥50 years (N=39) | EOCRC (N=27) |
---|---|---|---|
| |||
Age (n, %) | |||
26–29 | 0/1 (0.0) | - | 1/1 (100.0) |
30–34 | 0/1 (0.0) | - | 1/1 (100.0) |
35–39 | 0/4 (0.0) | - | 3/3 (100.0) |
40–44 | 1/20 (5.0) | - | 10/11 (90.9) |
45–49 | 1/23 (4.3) | - | 9/11 (81.8) |
50–54 | - | 3/17 (17.6) | - |
55–59 | - | 1/7 (14.3) | - |
60–64 | - | 1/8 (12.5) | - |
65–69 | - | 1/5 (20.0) | - |
70+ | - | 0/2 (0.0) | - |
| |||
Race (n, %) | |||
White | 1/9 (11.1) | 4/21 (19.0) | 19/22 (86.3) |
Black | 1/23 (4.3) | 0/5 (0.0) | 2/2 (100.0) |
Hispanic | 0/15 (0.0) | 2/7 (28.6) | 0/0 (0.0) |
Asian | 0/1 (0.0) | 0/5 (0.0) | 1/1 (100.0) |
Unknown | 0/0 (0.0) | 0/1 (0/0) | 2/2 (100.0) |
| |||
Sex (n, %) | |||
Female | 0/17 (0.0) | 2/14 (14.3) | 11/11 (100.0) |
Male | 2/21 (9.5) | 4/25 (16.0) | 13/16 (81.3) |
| |||
Cancer site (n, %) | |||
Colon | - | - | 3/3 (100.0) |
Rectum | - | - | 15/18 (83.3) |
Unspecified colorectal site | - | - | 6/6 (100.0) |
| |||
Stage (n, %) | |||
I | - | - | 4/4 (100.0) |
II | - | - | 1/1 (100.0) |
III | - | - | 5/5 (100.0) |
IV | - | - | 12/12 (100.0) |
Unknown | - | - | 2/5 (40.0) |
| |||
Tumor grade (n, %) | |||
Low, low/intermediate | - | - | 10/11 (90.9) |
Intermediate | - | - | 5/6 (83.3) |
High | - | - | 6/7 (85.7) |
Unknown | - | - | 3/3 (100.0) |
| |||
Survival status, overall (n, %) | |||
Alive | - | - | 18/21 (85.7) |
Deceased | - | - | 6/6 (100.0) |
| |||
Family history of cancer (n, %) | |||
Yes | - | - | 19/21 (90.5) |
No | - | - | 4/5 (80.0) |
Unknown | - | - | 1/1 (100.0) |
| |||
Family history of CRC (n, %) | |||
Yes | - | - | 8/9 (88.9) |
No | - | - | 15/17 (88.2) |
Unknown | - | - | 1/1 (100.0) |
| |||
History of IBD or chronic inflammation (n, %) | |||
Yes | - | - | 5/5 (100.0) |
No | - | - | 19/22 (86.4) |